Abcam Plc (ABCM) Gross Profit Margin starting from the fourth quarter 2022 to fourth quarter , Profitability Trends and Ranking, Fundamental Ratios - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Abcam Plc  (NASDAQ: ABCM)


Abcam Plc's Gross Profit Margin by quarter

Trends, Rankings, Statistics


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

ABCM Gross Profit Margin (Dec 31 2022)
Q4 		0
Q3 		0
Q2 		0
Q1
Y / Y Revenue Change -
Seq. Revenue Change -
Revenue In Millions $447.47
Gross Profit Margin 74.79 %
Gross Profit Margin Total Ranking # 849
Gross Profit In Millions $334.64
Y / Y Gross Profit Change -
Seq. Gross Profit Change -


Commenting fourth quarter 2022 Gross Profit Margin



Observing fourth quarter 2022 results within Biotechnology & Pharmaceuticals industry 19 other companies have achieved higher Gross Profit Margin. While Gross Profit Margin overall ranking has deteriorated relative to the three months before, from to 849.
Learn about Gross Margin
ABCM's Gross Profit Margin fourth quarter 2022 Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 20
Healthcare Sector # 162
Overall # 830

Gross Profit Margin Statistics
High Average Low
74.79 % 74.79 % 74.79 %
(Dec 31 2022)  


ABCM Gross Income Trends • More of ABCM's Profitabilty Ratios • ABCM Stock Quotes and Charts


Other Gross Profit Margin Profitability Ratios
ABCM's Cumulative Gross Profit Margin
Biotechnology & Pharmaceuticals Industry Gross Profit Margin Trends and Statistics
Healthcare Sector Gross Profit Margin Statistics
Gross Profit Margin Profitability Trends for overall market
ABCM's Gross Profit Margin Profitability versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Gross Profit Margin
Lowest Ranking Gross Profit Margin
Gross Profit Margin Profit Margin for ABCM's Competitors
Gross Profit Margin Profit Margin for Abcam Plc's Suppliers
Gross Profit Margin Profit Margin for ABCM's Customers

You may also want to know
ABCM's Annual Growth Rates ABCM's Profitability Ratios ABCM's Asset Turnover Ratio ABCM's Dividend Growth
ABCM's Roe ABCM's Valuation Ratios ABCM's Financial Strength Ratios ABCM's Gross Profit Growth
ABCM's Roa ABCM's Inventory Turnover Ratio ABCM's Growth Rates ABCM's Dividend Comparisons


Companies with similar Gross Profit Margin in the quarter ending Dec 31 2022, within Biotechnology & Pharmaceuticals Industry Gross Profit MarginDec 31 2022 MRQ Gross ProfitDec 31 2022 MRQ Revenue
Neurocrine Biosciences Inc   98.13 %$ 404.300  Millions$ 412.000  Millions
Biocryst Pharmaceuticals Inc   97.00 %$ 77.162  Millions$ 79.545  Millions
Argenx Se  96.56 %$ 826.582  Millions$ 856.013  Millions
Exelixis Inc   96.24 %$ 407.997  Millions$ 423.917  Millions
Tarsus Pharmaceuticals Inc   96.00 %$ 9.600  Millions$ 10.000  Millions
Lineage Cell Therapeutics Inc   94.67 %$ 1.813  Millions$ 1.915  Millions
Fennec Pharmaceuticals Inc   94.40 %$ 1.449  Millions$ 1.535  Millions
Ginkgo Bioworks Holdings Inc   92.42 %$ 90.838  Millions$ 98.285  Millions
Cellectis S a   90.76 %$ 17.399  Millions$ 19.171  Millions
Zeo Scientifix Inc   90.25 %$ 0.966  Millions$ 1.070  Millions
Vir Biotechnology Inc   87.86 %$ 43.414  Millions$ 49.410  Millions
Eiger Biopharmaceuticals Inc   87.20 %$ 2.351  Millions$ 2.696  Millions
Compugen Ltd  87.00 %$ 6.525  Millions$ 7.500  Millions
Miromatrix Medical inc   86.56 %$ 0.805  Millions$ 0.930  Millions
Acorda Therapeutics Inc   85.51 %$ 26.910  Millions$ 31.470  Millions
Gilead Sciences Inc   81.11 %$ 5,993.000  Millions$ 7,389.000  Millions
Seagen Inc   79.51 %$ 419.940  Millions$ 528.150  Millions
Biogen Inc   77.56 %$ 1,973.100  Millions$ 2,544.000  Millions
Halozyme Therapeutics Inc   76.79 %$ 139.376  Millions$ 181.496  Millions
Abcam Plc  74.79 %$ 334.642  Millions$ 447.467  Millions
Amgen Inc   74.46 %$ 5,092.000  Millions$ 6,839.000  Millions
Agenus Inc  72.90 %$ 20.692  Millions$ 28.385  Millions
Vericel Corporation  72.59 %$ 38.249  Millions$ 52.694  Millions
Protalix Biotherapeutics inc   72.18 %$ 6.220  Millions$ 8.617  Millions
Adaptive Biotechnologies Corporation  69.95 %$ 38.609  Millions$ 55.198  Millions
Creative Medical Technology Holdings Inc   69.35 %$ 0.013  Millions$ 0.019  Millions
Coherus Oncology inc   68.68 %$ 31.150  Millions$ 45.352  Millions
Bio techne Corp  67.52 %$ 183.360  Millions$ 271.581  Millions
Qiagen N v   66.53 %$ 1,384.563  Millions$ 2,081.035  Millions
Orchard Therapeutics Plc  65.17 %$ 4.553  Millions$ 6.986  Millions




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.